Industry Research Reports and Market Analysis at MindBranch.com

China Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Published By: Global Markets Direct
June 2009
R3480-13942
Online Download   $2,500.00
Global Site License   $7,500.00
Description

China Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to China diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in China

Scope
  • The report provides diabetes care devices information broken down into detailed categories and segments in China.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the diabetes care devices market in China.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 Diabetic Care Devices
3.2 Glucose Monitoring Devices
3.2.1 Blood Glucose Meters
3.2.2 Blood Glucose Strips
3.3 Insulin Delivery
3.3.1 InsulinPens
3.3.2 Insulin Syringes
3.3.3 Insulin Pumps
3.3.4 Traditional Insulin Pump Accessories
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.2.1 Healthcare Personnel Data
4.2.2 Healthcare Facilities Data
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Registration and Conformity assessment
5.1.3 China Compulsory Certificate (CCC Mark)
5.1.4 Labeling and Packaging
5.1.5 Registration Fee
5.1.6 Registration Period
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
7 Distribution Structure
8 Diabetes Care Devices In China
8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Diabetes Care Devices, China, Overall Revenue ($ mn), 2000-2015
8.3 Diabetes Care Devices, China, Category Volume (Units), 2000-2015
8.4 Diabetes Care Devices, China, Company Share (2007-2008)
9 Glucose Monitoring In China
9.1 Glucose Monitoring Overall Revenue (2000-2015)
9.1.1 Blood Glucose Meters Overall Revenue (2000-2015)
9.2 Glucose Monitoring Overall Volume (2000-2015)
9.2.1 Blood Glucose Meters Overall Volume (2000-2015)
9.3 Glucose Monitoring Average Price (2000-2015)
9.4 Glucose Monitoring Distribution Share (2007-2008)
9.5 Glucose Monitoring, China, Company Share (2007-2008)
10 Insulin Delivery In China
10.1 Insulin Delivery Overall Revenue (2000-2015)
10.1.1 Insulin Pens Overall Revenue (2000-2015)
10.2 Insulin Delivery Overall Volume (2000-2015)
10.2.1 Insulin Pens Overall Volume (2000-2015)
10.3 Insulin Delivery Average Price (2000-2015)
10.4 Insulin Delivery Distribution Share (2007-2008)
10.5 Insulin Delivery, China, Company Share (2007-2008)
11 Overview of Key Companies in China Diabetes Care Devices Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Value Chain Analysis
11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
11.2 LifeScan, Inc.
11.2.1 Company Overview
11.2.2 LifeScan, Inc. Pipeline Products
11.3 Medtronic, Inc.
11.3.1 Company Overview
11.3.2 Value Chain Analysis
11.3.3 Medtronic, Inc. Pipeline Products
11.4 Novo Nordisk A/S
11.4.1 Company Overview
11.4.2 Novo Nordisk A/S Pipeline Products
11.5 Becton, Dickinson and Company
11.5.1 Company Overview
11.5.2 Value Chain Analysis
11.6 ARKRAY, Inc.
11.6.1 Company Overview
11.6.2 ARKRAY, Inc. Pipeline Products
11.7 Terumo Corporation
11.7.1 Company Overview
11.7.2 Value Chain Analysis
11.8 Animas Corporation
11.8.1 Company Overview
11.9 Sanofi-Aventis
11.9.1 Company Overview
11.10 Smiths Medical
11.10.1 Company Overview
11.10.2 Value Chain Analysis
11.11 BIONIME Corporation
11.11.1 Company Overview
11.12 Bayer HealthCare AG
11.12.1 Company Overview
11.12.2 Value Chain Analysis
11.12.3 Bayer HealthCare AG Pipeline Products
11.13 Abbott Laboratories
11.13.1 Company Overview
11.13.2 Value Chain Analysis
11.13.3 Abbott Laboratories Pipeline Products
11.14 Apex Biotechnology Corp.
11.14.1 Company Overview
11.15 AViTA Corporation
11.15.1 Company Overview
11.16 Wuxi Xinda Medical Equipment Co., Ltd.
11.16.1 Company Overview
12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Coverage
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panel Validation
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer
1.1 List of Tables
Table 1: Doctors by Specialty in China, 2003-2007
Table 2: Hospital Wards by Specialty in China, 2003 - 2007
Table 3: Healthcare Institutions in China, 2000-2004
Table 4: Personnel Employed in Healthcare Institutions in China, 2000-2004
Table 5: Healthcare Institutions, Hospital Beds and Employed Personnel by Region in China, 2004
Table 6: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
Table 7: Diabetes Care Devices, China, Overall Revenue ($ mn), 2000-2015
Table 8: Diabetes Care Devices, China, Cross-Category Analysis, 2000-2015
Table 9: Diabetes Care Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
Table 10: Diabetes Care Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
Table 11: Diabetes Care Devices, China, Category Volume (Units), 2000-2015
Table 12: Diabetes Care Devices, China, Category Volume (Units), Historic, 2000-2008
Table 13: Diabetes Care Devices, China, Category Volume (Units), Forecast, 2008-2015
Table 14: Diabetes Care Devices, China, Company Share by Revenue ($ mn), 2007-2008
Table 15: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 16: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 17: Blood Glucose Meters, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 18: Blood Glucose Meters, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 19: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2008
Table 20: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2008-2015
Table 21: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 22: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 23: Glucose Monitoring, China, Average Price ($), Historic, 2000-2008
Table 24: Glucose Monitoring, China, Average Price ($), Forecast, 2008-2015
Table 25: Glucose Monitoring, China, Distribution Share by Revenue ($mn), 2007-2008
Table 26: Glucose Monitoring, China, Company Share by Revenue ($ mn), 2007-2008
Table 27: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 28: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 29: Insulin Pens, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 30: Insulin Pens, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 31: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2000-2008
Table 32: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2008-2015
Table 33: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 34: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 35: Insulin Delivery, China, Average Price ($), Historic, 2000-2008
Table 36: Insulin Delivery, China, Average Price ($), Forecast, 2008-2015
Table 37: Insulin Delivery, China, Distribution Share by Revenue ($mn), 2007-2008
Table 38: Insulin Delivery, China, Company Share by Revenue ($ mn), 2007-2008
Table 39: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
Table 40: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
Table 41: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
Table 42: LifeScan, Inc. Pipeline Products by Equipment Type
Table 43: LifeScan, Inc. Pipeline Products by Development Stage
Table 44: LifeScan, Inc. Pipeline Products by Therapy Area
Table 45: LifeScan, Inc. Pipeline Products by Clinical Trials
Table 46: LifeScan, Inc. Pipeline Products by News Summary
Table 47: Medtronic, Inc. Pipeline Products by Equipment Type
Table 48: Medtronic, Inc. Pipeline Products by Development Stage
Table 49: Medtronic, Inc. Pipeline Products by Therapy Area
Table 50: Medtronic, Inc. Pipeline Products by Clinical Trials
Table 51: Medtronic, Inc. Pipeline Products by News Summary
Table 52: Novo Nordisk A/S Pipeline Products by Equipment Type
Table 53: Novo Nordisk A/S Pipeline Products by Development Stage
Table 54: Novo Nordisk A/S Pipeline Products by Therapy Area
Table 55: Novo Nordisk A/S Pipeline Products by Clinical Trials
Table 56: ARKRAY, Inc. Pipeline Products by Equipment Type
Table 57: ARKRAY, Inc. Pipeline Products by Development Stage
Table 58: ARKRAY, Inc. Pipeline Products by Clinical Trials
Table 59: ARKRAY, Inc. Pipeline Products by News Summary
Table 60: Bayer HealthCare AG Pipeline Products by Equipment Type
Table 61: Bayer HealthCare AG Pipeline Products by Development Stage
Table 62: Bayer HealthCare AG Pipeline Products by Therapy Area
Table 63: Bayer HealthCare AG Pipeline Products by News Summary
Table 64: Abbott Laboratories Pipeline Products by Equipment Type
Table 65: Abbott Laboratories Pipeline Products by Development Stage
Table 66: Abbott Laboratories Pipeline Products by Therapy Area
Table 67: Abbott Laboratories Pipeline Products by Clinical Trials
Table 68: Abbott Laboratories Pipeline Products by News Summary
Table 69: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in China, 2000 - 2005
Figure 2: Medical Equipment Registration Process in China, 2007
Figure 3: CCC Mark Certification Process in China, 2007
Figure 4: Diabetes Care Device, Cross Country Comparison, Revenue ($ mn), 2000-2015
Figure 5: Diabetes Care Devices, China, Overall Revenue ($ mn), 2000-2015
Figure 6: Diabetes Care Devices, China, Cross-Category Analysis, 2000-2015
Figure 7: Diabetes Care Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
Figure 8: Diabetes Care Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 9: Diabetes Care Devices, China, Category Volume (Units), 2000-2015
Figure 10: Diabetes Care Devices, China, Category Volume (Units), Historic, 2000-2008
Figure 11: Diabetes Care Devices, China, Category Volume (Units), Forecast, 2008-2015
Figure 12: Diabetes Care Devices, China, Company Share (%), 2008
Figure 13: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2008
Figure 14: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
Figure 15: Blood Glucose Meters, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Figure 16: Blood Glucose Meters, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Figure 17: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2008
Figure 18: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2008-2015
Figure 19: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
Figure 20: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Figure 21: Glucose Monitoring, China, Company Share (%), 2008
Figure 22: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2008
Figure 23: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
Figure 24: Insulin Pens, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Figure 25: Insulin Pens, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Figure 26: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
Figure 27: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Figure 28: Insulin Delivery, China, Company Share (%), 2008
Figure 29: F. Hoffmann-La Roche Ltd Value Chain Analysis
Figure 30: Medtronic, Inc. Value Chain Analysis
Figure 31: Becton, Dickinson and Company Value Chain Analysis
Figure 32: Terumo Corporation Value Chain Analysis
Figure 33: Smiths Medical Value Chain Analysis
Figure 34: Bayer HealthCare AG Value Chain Analysis
Figure 35: Abbott Laboratories Value Chain Analysis
Figure 36: Global Markets Direct Methodology
Order Form
       * Please reference product number R3480-13942 when ordering or inquiring.
PUBLICATION:   China Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015
QTY. FORMAT PRICE TOTAL
  Online Download$2,500.00   
  Global Site License$7,500.00   
  SUBTOTAL   
SHIPPING CHARGES
 (U.S. $25, Canada $35, Int'l $65) 		 
TOTAL  

CONTACT INFORMATION
PAYMENT INFORMATION
Name ____________________________________________ MasterCard VISA AmEx Discover

__________________________________
Account number                 Exp. date

__________________________________
Signature

__________________________________
Email

Please invoice
      (shipment on receipt of payment)
Payment enclosed
*CHECKS / WIRE TRANSFERS:
Checks must be paid in U.S. funds.
Please call for details.
Company ____________________________________________
Job Title ____________________________________________
Address ____________________________________________
City ____________________________________________
Company ____________________________________________
State ______________________________   Zip__________
Country ____________________________________________
Phone ____________________________________________
MindBranch, Inc.,     131 Ashland St., Suite 200 North Adams, MA  01247       tel: 800-774-4410     fax: +1-413-664-9791     www.mindbranch.com